Chirag K.  Patel net worth and biography

Chirag Patel Biography and Net Worth

Chirag Patel has served as Co-Chief Executive Officer, President and director of the Company since August 2019. Mr. Patel served as a Co-Chairman of the Board from May 2018 to August 2019, and previously was Co-Founder of Amneal and served as Co-Chairman and Co-Chief Executive Officer of Amneal from 2005 to October 2017. With his brother, Chintu Patel, Mr. Patel has also invested in several independent biopharmaceutical companies including Asana Biosciences, Kashiv Biosciences and Prolong Pharmaceuticals, each of which specializes in innovative science and drug delivery technologies. Earlier in his career, Mr. Patel co-founded technology companies NextGen Technologies and Veriprise Wireless. Mr. Patel also serves as a Managing Trustee for the Liberty Science Center of New Jersey, a Director for the New Jersey City University Foundation and a Trustee for the Foundation for Morristown Medical Center. He is also a recipient of the 2011 Ernst & Young National Entrepreneur of the Year Life Sciences Award®. Mr. Patel supports various philanthropic causes and, together with his wife, Priti Patel, established the Niswarth International Foundation in 2013. The Foundation aims to bring fresh water, sanitation, nutrition and education to underprivileged children. Mr. Patel received his bachelor’s degrees in Commerce from H.A. College of Commerce, India, and in Business Administration from New Jersey City University. He also holds an honorary Doctorate of Humane Letters from New Jersey City University in recognition of his efforts to serve others.

What is Chirag K. Patel's net worth?

The estimated net worth of Chirag K. Patel is at least $248,155.32 as of March 4th, 2020. Mr. Patel owns 40,748 shares of Amneal Pharmaceuticals stock worth more than $248,155 as of March 28th. This net worth evaluation does not reflect any other assets that Mr. Patel may own. Additionally, Mr. Patel receives an annual salary of $1,440,000.00 as CEO at Amneal Pharmaceuticals. Learn More about Chirag K. Patel's net worth.

How old is Chirag K. Patel?

Mr. Patel is currently 57 years old. There are 3 older executives and no younger executives at Amneal Pharmaceuticals. The oldest executive at Amneal Pharmaceuticals is Mr. Andrew S. Boyer, Executive VP & Chief Commercial Officer of Generics, who is 58 years old. Learn More on Chirag K. Patel's age.

What is Chirag K. Patel's salary?

As the CEO of Amneal Pharmaceuticals, Inc., Mr. Patel earns $1,440,000.00 per year. The highest earning executive at Amneal Pharmaceuticals is Mr. Chintu Patel R.Ph., Co-Founder, Co-CEO & Director, who commands a salary of $1,460,000.00 per year. Learn More on Chirag K. Patel's salary.

How do I contact Chirag K. Patel?

The corporate mailing address for Mr. Patel and other Amneal Pharmaceuticals executives is 400 Crossing Boulevard, 3rd Floor, Bridgewater, NJ 08807, United States. Amneal Pharmaceuticals can also be reached via phone at 908-947-3120 and via email at [email protected]. Learn More on Chirag K. Patel's contact information.

Has Chirag K. Patel been buying or selling shares of Amneal Pharmaceuticals?

Chirag K. Patel has not been actively trading shares of Amneal Pharmaceuticals during the last quarter. Most recently, on Wednesday, December 15th, Chirag K. Patel bought 100,000 shares of Amneal Pharmaceuticals stock. The stock was acquired at an average cost of $4.13 per share, with a total value of $413,000.00. Learn More on Chirag K. Patel's trading history.

Who are Amneal Pharmaceuticals' active insiders?

Amneal Pharmaceuticals' insider roster includes Chirag Patel (CEO), Gautam Patel (Director), Nikita Shah (EVP), and Joseph Todisco (EVP). Learn More on Amneal Pharmaceuticals' active insiders.

Are insiders buying or selling shares of Amneal Pharmaceuticals?

During the last year, insiders at the sold shares 1 times. They sold a total of 29,302 shares worth more than $121,017.26. The most recent insider tranaction occured on August, 11th when EVP Andrew S Boyer sold 29,302 shares worth more than $121,017.26. Insiders at Amneal Pharmaceuticals own 26.6% of the company. Learn More about insider trades at Amneal Pharmaceuticals.

Information on this page was last updated on 8/11/2023.

Chirag K. Patel Insider Trading History at Amneal Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/15/2021Buy100,000$4.13$413,000.00View SEC Filing Icon  
3/4/2020Buy58,938$3.97$233,983.8640,748View SEC Filing Icon  
3/2/2020Buy34,641$3.87$134,060.6740,748View SEC Filing Icon  
See Full Table

Chirag K. Patel Buying and Selling Activity at Amneal Pharmaceuticals

This chart shows Chirag K Patel's buying and selling at Amneal Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Amneal Pharmaceuticals Company Overview

Amneal Pharmaceuticals logo
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment offers immediate and extended release oral solid, powder, liquid, sterile injectable, nasal spray, inhalation and respiratory, biosimilar, ophthalmic, film, transdermal patch, and topical products. The Specialty segment develops, promotes, sells, and distributes pharmaceutical products with focus on central nervous system disorders, including Parkinson's disease, and endocrine disorders. This segment also provides Rytary, an oral capsule formulation of carbidopa-levodopa to treat Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism; Unithroid for the treatment of hypothyroidism; and IPX203, a pipeline product for Parkinson's disease. The AvKARE segment offers pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. This segment also distributes bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names; and packages and distributes pharmaceuticals and vitamins to its retail and institutional customers. It sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.
Read More

Today's Range

Now: $6.06
Low: $5.97
High: $6.21

50 Day Range

MA: $5.61
Low: $5.24
High: $6.34

2 Week Range

Now: $6.06
Low: $1.26
High: $6.46

Volume

2,883,313 shs

Average Volume

1,507,589 shs

Market Capitalization

$1.86 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32